Elephas Biosciences is a startup based in the United States, most recent round Series B, 2 tracked investors.
Elephas Biosciences is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Elephas Biosciences develops the elive™ platform, a live-tissue technology designed to predict immunotherapy response with unprecedented precision by analyzing cytokine activity in live tumor fragments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.